Phagocytosis is a process whereby particles are taken in by cells through mechanisms superficially similar to those for endocytosis. It serves a wide range of functions, from providing nutrition in unicellular organisms to initiation of both innate and adaptive immunity in vertebrates. In the protozoan parasite Entamoeba histolytica, it has an essential role in survival and pathogenesis. In this study, we show that EhC2PK, a C2-domain-containing protein kinase, and the Ca2+ and actin-binding protein, EhCaBP1, are involved in the initiation of phagocytosis in E. histolytica. Conditional suppression of EhC2PK expression and overexpression of a mutant form reveals its role in the initiation of phagocytic cups. EhC2PK binds phosphatidylserine in the presence of Ca2+ and thereby recruits EhCaBP1 and actin to the membrane. Identification of these proteins in phagocytosis is an important step in amoebic biology and these molecules could be the important targets for developing novel therapies against amoebiasis.
Phagocytosis has a critical role in the biology and pathogenesis of the protozoan parasite Entamoeba histolytica. Trophozoites partly source their nutrients by phagocytosis of bacterial and other cells found in the intestine. The trophozoites then digest the cells and re-utilize the nutrients1,2. Erythrophagocytosis is a pathogenic marker of amoebiasis and it occurs frequently during invasive disease3. Phagocytosis of dead epithelial, immune and nonimmune cells is also thought to be one of the important features of amoebic pathogenesis4,5. So far no defined receptor(s) or ligand(s) that initiate phagocytosis in E. histolytica have been identified. Although there is some evidence to suggest that Gal/GalNAc lectin is likely to be one of the phagocytosis receptors, engagement of the lectin does not always lead to phagocytosis6,7.
In mammalian cells, the most studied phagocytic system is Fc receptor-mediated phagocytosis. The process is initiated when FcR on the surface of a phagocyte binds to immunoglobulin-coated opsonized particles. At sites of phagocytosis, the plasma membrane is pulled around the target particles leading to the formation of phagocytic cups8. This is followed by constriction at the distal margins of the cup that results in closure of the phagosome. Transient assembly of actin filaments and myosin-dependent contractile activities have critical roles in different steps of this process9. Initiation of phagocytosis is achieved by ligand-induced Fcγ receptor clustering that leads to the activation of membrane associated Src family of kinases10 that phosphorylate the immune-receptor tyrosine-based activation motif of FcR, which in turn recruits the syk family of tyrosine kinases11. syk kinase phosphorylates PI3K resulting in the presence of PI3K close to the clustered FcR region of the membrane12. A nonphagocytic cell can be induced to initiate phagocytosis by expression of FcR and syk, suggesting that syk has an important role in phagocytic signal transduction from FcR7. In the presence of PI3K inhibitors, incomplete phagosomes appear as actin-rich phagocytic cups, suggesting that PI3K may be involved in organizing the later stages of phagocytosis13,14,15. Ca2+ signals are generated subsequent to the activation of FcγR through downstream processes that involve activation of PLCγ and are required for phagosome closure and maturation mainly through actin remodeling16. It is not clear whether Ca2+ signalling has any role in the process of initiation.
A number of molecules have been implicated to participate in amoebic phagocytosis, although many of the known players of the mammalian system have not been identified in this organism. Therefore, phagocytosis in E. histolytica is likely to follow a different molecular path. Some of the molecules that have been identified are components of the cytoskeleton17 and its regulators18,19,20,21,22,23,24,25 including phosphoinositides and one of the FYVE-domain-containing protein EhFP426. Analysis of the phagosome proteome has revealed involvement of a large number of proteins in phagosome formation and subsequent maturation27,28. The list includes novel proteins, such as phagosome-associated transmembrane kinase and the serine-rich E. histolytica protein29. Cytoplasmic Ca2+ is known to be involved in the process of phagocytosis. However, no mechanistic details about the process of initiation or the involvement of Ca2+ are available.
Although much progress has been made in deciphering the pathways leading to phagocytosis in different organisms including E. histolytica, the early events of the process remain to be discovered. Our previous studies have shown the involvement of E. histolytica calcium-binding protein (EhCaBP1) in actin dynamics. Downregulation of this protein leads to defects in both phagocytosis and pseudopod formation30. EhCaBP1 binds both G- and F-actin in vitro and in vivo. The absence of this molecule in the phagosome and its rapid recruitment at the site of phagocytosis (total time from its appearance to its eventual disappearance spans about 30–40 s) suggests that EhCaBP1 may be involved in events just subsequent to the attachment of ligand particles31. To explore the events just before the appearance of EhCaBP1 at the phagocytosis site, we decided to look for the proteins that bind to EhCaBP1 and test their involvement in phagocytosis. EhC2PK, a novel C2-domain-containing protein kinase, was identified as an EhCaBP1-binding protein. In this report, we show that EhC2PK along with EhCaBP1 is required for the initiation of phagocytosis in E. histolytica. We have used both antisense and dominant negative approaches for functional dissection. Our results indicate that erythrophagocytosis is initiated by the recruitment of EhC2PK at the site of red blood cell (RBC) attachment and then subsequently the recruitment of EhCaBP1 and actin. We are also able to distinguish steps that require Ca2+ from those that do not. Thus, identification of these proteins involved in parasite phagocytosis may provide targets for therapeutic intervention in parasite-mediated disease.
Identification of EhC2PK as an EhCaBP1-binding protein
Affinity chromatography using EhCaBP1-Sepharose columns resulted in elution of a number of proteins that bound to EhCaBP1 as described before32. The bound proteins were identified by mass spectrometric analysis (Supplementary Table S1). The binding proteins included actin, a known binding partner of EhCaBP1, and a C2-domain-containing protein kinase (EhC2PK), which was selected for further study (Fig. 1a). EhC2PK differs from typical PKCs with respect to the absence of a C1 domain, which is necessary for the interaction with diacylglycerol. Sequence similarity searches using the kinase domain of EhC2PK showed maximum identity (45%) with Ca2+/CaM-dependent protein kinases of humans, but not with other C2-domain-containing kinases. We conclude from these observations that EhC2PK is distinctly different from other C2-domain-containing protein kinases, including PKC.
We confirmed binding of the two proteins by immunoprecipitation using an immobilized anti-EhC2PK antibody and the total cell lysate of E. histolytica trophozoites. EhC2PK antibody precipitated not only EhC2PK, but also EhCaBP1 from the total cell lysate (Fig. 1b). EGTA did not affect the interaction between the two molecules. This interaction is highly specific as EhCaBP2, a protein with high sequence similarity with EhCaBP1 (79% identity at the amino-acid level) but with a different function33, was not detected in the immunoprecipitate. Our data show that the EhC2PK and EhCaBP1 interaction does not require Ca2+ in spite of both proteins being calcium-binding proteins. To demonstrate the interaction of EhC2PK with EhCaBP1 in vitro, we expressed EhC2PK as a GST-tagged protein and incubated it with EhCaBP1. The protein complex was obtained by binding to glutathione-Sepharose and EhCaBP1 was detected using a specific antibody by western blotting (Fig. 1c). There was no nonspecific binding of EhCaBP1 to the beads as no signal was detected in the lane containing glutathione-S-transferase (GST) alone. We checked whether an intact kinase domain is required for this binding by carrying out an in vitro binding assay using GST-tagged wild-type (WT) EhC2PK, a kinase-dead mutant (K179A) and the kinase domain alone (Fig. 1c). The kinase domain alone is functionally active as it can autophosphorylate as well as phosphorylate external substrates, such as histone and myelin basic protein. The K179A mutant did not show any kinase activity. Both the WT and kinase-dead mutant bound EhCaBP1, but the kinase domain alone could not bind to EhCaBP1 (GST-KD; Fig. 1c). A mutant form of EhCaBP1 (CaBP1ΔEF), which is defective in Ca2+-binding31, was also able to bind WT and the K179A mutant of EhC2PK. Taken together, these experiments indicate that EhCaBP1 is an interacting partner of EhC2PK and that binding does not require the kinase domain or Ca2+. The C2 domain may be involved in this binding; however, we could not test the direct interaction of the C2 domain with EhCaBP1, as the C2 domain was insoluble under binding conditions.
EhC2PK binds phosphatidylserine and recruits EhCaBP1 and actin
C2 domains generally display the property of Ca2+-dependent lipid binding. When compared with all known C2 domains, that of EhC2PK shows a maximum identity of 30% with C2 domains of Ca2+-dependent PKCβ and -γ of Homo sapiens (Supplementary Fig. S1). However, it is smaller in length compared with other C2 domains, including the C2 domain of amoebic protein EhC2A. As the C2 domain of EhC2PK is somewhat different from other C2 domains, we tested the ability of the C2 domain of EhC2PK to bind Ca2+ using a 45Ca2+ overlay assay (Supplementary Fig. S2). The binding of radioactive Ca2+ to the purified C2 domain band in the blot confirmed the ability of this protein to bind Ca2+. As EhCaBP1 binds to EhC2PK, it is possible that it is recruited to the plasma membrane through binding to EhC2PK. To test this we first checked the ability of EhC2PK and then both EhC2PK and EhCaBP1 to bind phospholipid liposomes in the presence and absence of Ca2+. We mixed the liposomes with the indicated proteins and the binding was assessed by sedimentation and western blotting. The sedimentation of EhC2PK along with liposomes, in the presence of Ca2+ but not EGTA, suggested that EhC2PK binds phosphatidylserine in a Ca2+-dependent manner (Fig. 2a). We did not observe any binding when the kinase domain alone was used in the liposome sedimentation assay (Fig. 2b). We could not test the ability of the C2 domain to bind lipids and EhCaBP1 because of the insoluble nature of C2 peptide as mentioned previously. We did not observe binding of EhCaBP1 to the liposomes in the presence of Ca2+ or EGTA (Fig. 2c). GST was used as a control to show that the tag by itself did not bind to liposomes (Fig. 2c). We incubated liposomes with EhC2PK and EhCaBP1 together and found both the proteins in the pellet fraction in the presence of Ca2+, suggesting that EhCaBP1 can bind to liposomes only through EhC2PK and this required Ca2+ (Fig. 2a). We investigated the specificity of the interaction between EhC2PK and phospholipids using phosphatidylcholine (PC) instead of phosphatidylserine. We did not observe any protein in the pellet, suggesting that EhC2PK preferentially binds phosphatidylserine. The GST-tagged full-length protein did not bind to PC liposomes either in the presence or in the absence of Ca2+ as all the protein was found in supernatant (Fig. 2d). The purified kinase domain alone also did not bind to liposomes (Fig. 2e). Furthermore, GST and EhCaBP1 did not bind PC-containing liposomes in the presence of Ca2+, as none of the proteins were present in the liposome pellet (Fig. 2f,g). These findings are consistent with the properties of other C2-domain-containing proteins, in which binding to phosphatidylserine is mediated through the C2 domain34,35. We conclude from these results that EhCaBP1 binds lipids through EhC2PK and this interaction is lipid-specific and requires the presence of Ca2+. Further, we carried out experiments to investigate whether liposomes-containing EhC2PK and EhCaBP1 are able to bind to actin filaments. We observed that liposomes incubated with EhC2PK and EhCaBP1 could bind to actin filaments in a Ca2+-dependent manner, whereas liposomes incubated with just EhCaBP1 or EhC2PK could not (Supplementary Fig. S3).
We extended our studies to investigate the role of Ca2+ in the membrane localization of EhC2PK using immunofluorescence. In amoebic cells, the majority of stained EhC2PK is found near the plasma membrane with some amount in the cytoplasm (Fig. 2h). When we treated the cells with the ionophore ionomycin, almost all of the fluorescence was located at the plasma membrane (Fig. 2i). However, when we depleted the free cytoplasmic Ca2+ with BAPTA-AM, only cytoplasmic fluorescence was observed (Fig. 2j). These results support our in vitro observations regarding the requirement of Ca2+ in membrane localization of EhC2PK. The results of this study together with our earlier observations regarding the ability of a mutant protein, CaBP1ΔEF, which is defective in binding Ca2+ in recruitment to the phagocytic cups31, suggests that Ca2+ is required for membrane localization of EhC2PK but not for its binding to EhCaBP1.
The C2 domain is involved in membrane localization of EhC2PK
To check whether the C2 or the kinase domain is involved in lipid binding and membrane localization, we checked the ability of the domains to bind lipids or membranes in vivo. Membrane binding in cells was checked by expressing individual domains of the protein in E. histolytica cells as GFP tags (Fig. 3a). We first showed that the GFP tag did not alter the property of the EhC2PK, as we observed similar distribution of immunostained EhC2PK and EhC2PK-GFP in amoebic cells (Fig. 3b,c). Green fluorescent stains of EhC2PK-GFP were clearly visible on phagocytic cups and these colocalized with actin. The distributions of KD-GFP and C2-GFP were also observed in their respective cell lines (Fig. 3d,e). Although KD-GFP was mainly seen in the cytoplasm, C2-GFP was essentially found at the membrane, consistent with our results from in vitro studies. Hence, the membrane localization of EhC2PK is determined by the C2 domain of the protein.
EhC2PK is involved in erythrophagocytosis
We generated conditional EhC2PK knockdown cells (Fig. 4a) using tetracycline inducible antisense expression, as previously described30. Overexpression of antisense EhC2PK RNA in the presence of tetracycline specifically reduced the level of EhC2PK by about 70% without affecting the levels of EhCaBP1 (Fig. 4b). We also generated cells that overexpress EhC2PK (Fig. 4c) and the K179A mutant by cloning the gene in the sense orientation in the tetracycline inducible vector system. Erythrophagocytosis in these cell lines was measured in the presence and absence of tetracycline. We observed 68 and 50% reduction in erythrophagocytosis by cells expressing the antisense gene and K179A mutant, respectively, compared with the cells containing vector alone (Fig. 4d). Cells with the gene in the sense orientation and grown in the presence of tetracycline and cells with the gene in antisense orientation grown in the absence of tetracycline showed similar levels of phagocytosis (Fig. 4d). To further understand the involvement of EhC2PK in erythrophagocytosis we carried out immunostaining; EhC2PK was found at the phagocytic cups along with EhCaBP1 and actin (Fig. 4e,f). The enrichment of these molecules at the phagocytic cups was quantified by determining the amount of stain in phagocytic cups compared with the staining intensity of the other regions of the membrane. We did not observe EhC2PK in newly formed phagosomes (Fig. 4g), nor did we see any phagocytic cup formation in the antisense cell lines (EhC2PK AS), although a number of RBCs were attached to the membrane (Fig. 4h). As a control for membrane staining, we used the membrane protein EhTMK-9 that uniformly stains the plasma membrane of E. histolytica36 (Fig. 5a). EhTMK-9 is also found in newly formed phagosomes and along with actin that can be used as a marker for phagosomes. Quantitative analysis of specific immunostaining showed a significantly higher level of EhC2PK in the phagocytic cups compared with other parts of the membrane (Fig. 5b). EhTMK-9 stained both the phagocytic cups and the rest of the plasma membrane equally (Fig. 5b). There was no significant difference in the intensity of EhTMK-9 in the nonphagocytic part of the membrane and in phagocytic cups. However, there was a significant increase in the EhC2PK stain in phagocytic cups compared with any other parts of the membrane. Quantitative analysis of the specific immunostains showed the presence of EhTMK-9 and the lack of EhC2PK in the phagosomes (Fig. 5c). Similar analysis with EhCaBP1 antibody also showed significant enrichment of EhCaBP1 in phagocytic cups but not in phagosomes (Supplementary Fig. S4).
In general, proteins that are known to be involved in phagocytosis are found in phagosomes27. In previous studies, the phagosome proteome was investigated to identify proteins that may be involved in phagocytosis. Although many known proteins involved in phagocytosis were found in the proteome, neither EhC2PK nor EhCaBP1 was among the list of proteins in two different studies28,29. The absence of both EhC2PK and EhCaBP1 in phagosomes, suggests that these may be exclusively associated with the early steps of phagocytosis.
We next determined whether the process of phagocytosis is delayed in the antisense cell line by observing cup formation at different times after addition of RBCs. At 3 min, there was no initiation of phagocytosis in these cells or in cells containing the C2 domain alone or the K179A mutant (Fig. 6a). However, on longer incubation (5 and 8 min), initiation was observed in these cell lines, suggesting that the rate of initiation has slowed down (Fig. 6a,b). We also measured the ability of these overexpressing cell lines to take up RBCs. Overexpression of the full-length protein resulted in an enhanced level of erythrophagocytosis. Reduction of uptake was observed only when the C2 domain was overexpressed, thereby displaying a dominant negative phenotype (Fig. 6c). We did not observe any significant difference in the rate of phagocytosis in cells overexpressing the kinase domain. Although kinase domain overexpression did not give a dominant negative phenotype, its functional involvement was evident in the cell lines induced to overexpress the kinase-dead mutant (Fig. 4d). These results indicate that EhC2PK, similar to EhCaBP1, is also involved in the process of erythrophagocytosis and that these proteins are essential for the process of initiation of phagocytosis. C2-GFP and EhC2PK (K179A) were observed to be enriched in phagocytic cups along with EhCaBP1 after 8 min of incubation in cells overexpressing these proteins (Fig. 6d,e). The overexpression of mutant proteins delayed the rate of erythrophagocytosis by competing with the endogenous WT protein. This result indicates that the C2 domain alone is sufficient for recruiting EhCaBP1 to phagocytic cups.
To distinguish between recruitment and subsequent signal transduction processes we carried out colocalization experiments with C2-GFP, the kinase-dead mutant of EhC2PK-GFP, EhCaBP1 and actin during erythrophagocytosis and pseudopod formation. Pairwise analysis of these proteins clearly showed that the C2 domain alone could colocalize with EhCaBP1 and actin (Fig. 7). We also found enrichment of EhCaBP1 at the phagocytic cups in cells overexpressing the kinase-dead mutant of EhC2PK. Therefore, it seems that the recruitment process does not require the kinase domain, but it is necessary in subsequent steps. The interaction of a C2-domain-containing kinase with a multi-EF hand Ca2+-binding protein is unique, as no such examples are known from any other system.
In this study, we show the involvement of two novel molecules, EhC2PK and EhCaBP1, in the initiation of erythrophagocytosis in E. histolytica. Phagocytosis is a fundamental process in a variety of cell types and involves initiation and subsequent closure and maturation of the phagosome. The best-studied system is the phagocytosis of opsonized bacteria through immunoglobulin Fc receptors. Here, the process is initiated by the occupancy of receptors and their clustering, which leads to activation of a protein kinase, such as syk11. Receptor activation also stimulates class I PI3K through phosphorylation of the p85 regulatory subunit. This causes production of PtdIns(3,4,5)P3 beneath the phagocytic cups, and activation of PLC and PLD. Ca2+ is released, which mobilizes InsP312. Therefore, Ca2+ is thought to have a major role in phagosome closure and maturation, mainly due to the process of actin remodeling35,36.
The mechanism of initiation of phagocytosis is not clear and many of the participating molecules have not yet been identified. This is particularly so in protozoa. In E. histolytica, it has not been possible to study initiation as a distinct process separate from closure and maturation, partly due to the short duration of the process and the lack of information regarding phagocytic receptors on the cell surface of E. histolytica. Here, we have delineated the initial steps in the phagocytic process. The first step in which Ca2+ is required is the recruitment of EhC2PK at the RBC attachment sites. In the absence of Ca2+, most of the EhC2PK is present in the cytoplasm and phagocytosis cannot be initiated. This is followed by the recruitment of EhCaBP1 and actin. Overexpression of the C2 domain and the kinase-dead mutant of EhC2PK allowed formation of the initiation complex, but the process of phagosome formation was blocked; suggesting that progression of phagocytic cups to phagosomes requires additional steps, likely to involve the kinase domain of EhC2PK. As phagocytic cups did not form in cells overexpressing the kinase-dead mutant, it is likely that the kinase activity of EhC2PK may be needed for stabilization of the cups whose formation is initiated at the site of RBC attachment. We had earlier observed the presence of phagocytic cups but not phagosomes in cells overexpressing mutant CaBP1ΔEF, which can not bind Ca2+ (ref. 31). Therefore, overexpression of the kinase-dead mutant form of EhC2PK and CaBP1ΔEF led to slightly different phenotypes and suggested that Ca2+ signalling through EhCaBP1 may be required after participation of EhC2PK. These results show that the transition from initiation of phagocytosis to phagosome formation requires multiple steps, which include kinase reaction of EhC2PK and Ca2+-based signalling from EhCaBP1, apart from other factors described in the previous studies7. The absence of EhC2PK and EhCaBP1 from phagosomes is a clear indicator that their role is primarily in the process of initiation. The proposed mechanism also explains the process by which a predominantly cytoplasmic protein, EhCaBP1, accumulates at the membrane of the phagocytic cup. We are currently searching for additional molecules that may also be involved in the initiation steps.
A number of C2-domain-containing proteins, such as PKCs, phospholipases and PI3K are known to participate in phagocytosis37,38,39. Though their role in phagosome closure is well documented, it is not clear whether these are also involved in the initiation. Phosphoinositides are also known to be important molecules in phagocytosis39. Inhibitors of PI3 kinase block erythrophagocytosis. In E. histolytica, these molecules participate mostly during the closing step of phagosome formation and not at the initiation step26. EhC2PK is different from all C2-domain-containing proteins that participate in phagocytosis. This is the first example of the direct participation of two Ca2+-binding proteins, EhC2PK and EhCaBP1, in the initiation of phagocytosis. Though there may be significant differences in the mechanisms of phagosome initiation in different organisms, and a variety of molecules may be involved in the process, it is likely that a similar theme may be operational in other systems. Moreover, phagocytosis is an essential process in many organisms including E. histolytica in which cellular proliferation is inhibited on blocking phagocytosis30. Unravelling the mechanism of phagocytosis may be helpful in finding novel targets for the development of new therapeutics.
Growth and maintenance of parasites
E. histolytica strain HM-1: IMSS and all transformed parasites were maintained and grown in TYI-S-33 medium containing 125 μl of 250 U ml−1 benzyl penicillin and 0.25 mg ml−1 streptomycin per 100 ml of medium30. The transformants containing tetracycline inducible system were grown in the presence of 10 μg ml−1 of hygromycin B. The cells were first grown for 48 h (60–70% confluent) and then 20 μg ml−1 tetracycline was added to the medium for 36 h for induction. Cells carrying constructs with constitutive expression system (such as GFP) were maintained at 10 μg ml−1 of G418. But the experiments were carried out in the presence of 30 μg ml−1 of G418.
Transfection and selection of E. histolytica trophozoites
Transfection was performed by electroporation. The trophozoites were collected from log phase cultures and washed with PBS followed by incomplete cytomix buffer (10 mM K2HPO4/KH2PO4 (pH 7.6), 120 mM KCl, 0.15 mM CaCl2, 25 mM HEPES (pH 7.4), 2 mM EGTA, 5 mM MgCl2). The washed cells were then re-suspended in 0.8 ml of complete cytomix buffer (incomplete cytomix containing 4 mM adenosine triphosphate, 10 mM glutathione) containing 200 mg of plasmid DNA and subjected to two consecutive pulses of 3,000 V cm−1 (1.2 kV) at 25 mF (Bio-Rad, electroporator). The transfectants were initially allowed to grow without any selection. Drug selection was initiated after 2 days of transfection in the presence of 10 μg ml−1 G418 for constructs with GFP or 10 μg ml−1 of hygromycin B was used for tetracycline inducible constructs.
Cloning of various constructs used
The CAT gene of the shuttle vector pEhHYG-tetR-O-CAT was excised using KpnI and BamHI and EhC2PK gene was inserted in its place in either the sense or the antisense orientation. Antisense and Sense forward and reverse primers used are shown in Supplementary Table S2. The full-length gene was cloned in BamH1 site in the case of GFP vector resulting in GFP tag on amino terminal of protein. Kinase domain was also cloned in constitutive (GFP) vector in BamH1 site. The C2-GFP was made by introducing stop codon at 103 amino-acid residue by site-directed mutagenesis. Also K mutant was made by site-directed mutagenesis by changing 179th lysine to alanine. The sequences of oligonucleotides used for making the above stated constructs are described in Supplementary Table S2.
Immunoprecipitation from E. histolytica lysate
Anti-EhC2PK antibody was conjugated to CNBr-activated Sepharose for immunoprecipitation. CNBr-activated Sepharose-4B (1 g, Pharmacia) was activated and processed as per the manufacturer's protocol. Briefly, crude immunoglobulins were collected from the immunized serum using 40% ammonium sulphate and subsequently dialysed in coupling buffer (bicarbonate buffer). Usually, 10 mg protein was added per gram of resin. The resin was mixed gently for 18 h at 4 °C. After coupling the coupled resin was processed as per manual provided by the manufacturer. The conjugated CNBr-Sepharose beads were incubated with E. histolytica lysate for 4 h at 4 °C. The beads were then washed with wash buffer (10 mM Tris-Cl (pH 7.5), 150 mM NaCl, 1 mM imidazol, 1 mM magnesium acetate, 2 mM β-ME and protease inhibitor cocktail) three times. The Ca2+ and EGTA were maintained throughout the process as required. Beads were washed with 60 mM Tris-Cl (pH 6.8) and 100 mM NaCl. Finally, beads were washed with 60 mM Tris-Cl (pH 6.8). The pellet was suspended in 2× SDS polyacrylamide gel electrophoresis (PAGE) buffer and boiled for 5 min followed by centrifugation for 5 min. The proteins were then analysed by western blotting.
E. histolytica cells were collected by centrifugation and washed before re-suspending in TYI-33 medium. The cells were then transferred onto acetone-cleaned coverslips placed in a petri dish and allowed to adhere for 10 min at 35.5 °C. The culture medium was removed and the cells were fixed with 3.7% pre-warmed paraformaldehyde for 30 min. After fixation, the cells were permeabilized with 0.1% Triton X-100/PBS for 1 min. The fixed cells were then washed with PBS and quenched for 30 min in PBS containing 50 mM NH4Cl. The coverslips were blocked with 1% BSA/PBS for 30 min, followed by incubation with primary antibody at 37 °C for 1 h. The coverslips were washed with PBS followed by 1% BSA/PBS before incubation with secondary antibody for 30 min at 37 °C. Antibody dilutions used were: anti-EhC2PK at 1:200, anti-EhCaBP1 at 1:200, anti-rabbit Alexa 488 and 556, anti-mice Alexa556 (Molecular Probes) at 1:300, TRITC-Phalloidin at 1:250. The preparations were further washed with PBS and mounted on a glass slide using DABCO (1,4-diazbicyclo (2,2,2) octane (Sigma) 2.5% in 80% glycerol). The edges of the coverslip were sealed with nail-paint to avoid drying. Confocal images were visualized using an Olympus Fluoview FV1000 laser scanning microscope.
Ten million RBCs were washed with PBS and incomplete TYI-33. These were then incubated with 105 entamoeba for varying times at 37 °C in 0.5 ml of culture medium. The entamoebae and erythrocytes were centrifuged to get a pellet, non-engulfed RBCs were lysed with cold distilled water and re-centrifuged at 1,000 g for 2 min. This step was repeated twice, followed by re-suspension in 1 ml formic acid to lyse entamoebae containing engulfed RBCs. The absorbance was measured at 400 nm.
The liposomes were prepared as per protocol provided by Avanti Polar Lipid, Inc. http://avantilipids.com. The proteins were incubated with liposomes in binding buffer (Tris-Cl (pH 7.5) 10 mM, β-ME 0.25 mM, NaCl 50 mM). CaCl2 was used at 2 mM wherever mentioned and EGTA was used at concentration of 5 mM at 37 °C for 2 h with intermittent tapping. The liposomes were centrifuged at 18,000 g for 30 min and subsequently washed with binding buffer to remove the nonspecific-binding proteins. Liposomes were than dissolved in SDS buffer and separated on SDS–PAGE and subsequently analysed for the presence of proteins by western analysis. For actin-binding assay the liposomes were incubated in polymerization buffer (Tris-Cl (pH 7.5) 10 mM, MgCl2 20 mM, KCl 50 mM, ATP 2.5 mM, β-ME 2.5 mM) with EhC2PK, EhCaBP1 and actin.
GST-bead pull down assay
Purified GST-EhC2PK was incubated with Glutathione beads (Amersham) for 1 h at 4 °C in 1% PBS/BSA. Then EhCaBP1 or E. histolytica lysate as indicated was added to the reaction and incubated for 2 h at 4 °C. The beads were then washed with 1% PBS/BSA three times, and twice with PBS. Protein was eluted by adding 2× SDS–PAGE buffer followed by boiling for 5 min. The proteins were then analysed by western blotting. The same procedure was followed for other proteins with GST-tags.
For immunodetection, samples were separated on 8% SDS–PAGE. The gel was then transferred on to a polyvinylidine fluoride membrane and processed using standard methods. The antigens were detected with polyclonal antibodies raised in rabbit and mice followed by secondary anti-rabbit and anti-mice immunoglobulins conjugated to HRPO (1:10,000, Sigma). ECL reagents were used for visualization (Millipore). GFP and GST antibodies used were obtained from Molecular probes and Santa Cruz, respectively. The concentration of proteins in a sample was estimated by bicinchoninic acid assay using BSA as a standard. SDS–PAGE analysis was carried out in 10–12% acrylamide gels under reducing conditions according to the method of Laemmli.
Statistical comparisons were made using a one-way ANOVA test. Experimental values were reported as the means±s.e. Differences in mean values were considered significant at P<0.05. All calculations of statistical significance were made using the GraphPad InStat software package (GraphPad).
How to cite this article: Somlata et al. A C2 domain protein kinase initiates phagocytosis in the protozoan parasite Entamoeba histolytica. Nat. Commun. 2:230 doi: 10.1038/ncomms1199 (2011).
We acknowledge Neetu Singh and Vishal Gupta from 'Advanced Instrument Research Facility', JNU for confocal imaging. Somlata acknowledges CSIR, India for Junior and Senior Research fellowships. Alok Bhattacharya thanks Department of Science and Technology for JC Bose Fellowship, funding from Department of Biotechnology and a donation from BNP Paribas. The authors also thank Dr N.S. Rao for help in structure-based alignment.
Supplementary Figures S1-S4 and Supplementary Tables S1-S2